Hjem › Melanom › Connecticut › New Haven
Melanom kliniske forsøg i New Haven, CT
10 studier for Melanom søger deltagere på steder i og omkring New Haven (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Yale Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- og 1 flere
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
- Yale Cancer Center, New Haven
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- Yale University, New Haven
Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekruttererFase 1/2
- Yale School of Medicine, North Haven · 7 mi væk
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruttererFase 1/2
- Yale University, New Haven
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Yale University, New Haven
- Smilow Hospital Care Center, Guilford, Guilford · 13 mi væk
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
RekruttererFase 2
- Yale, New Haven
Melanom forsøg i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- St. Louis, MO21 studier
- Salt Lake City, UT21 studier
Andre studier i New Haven
- Ikke-småcellet lungecancer41 studier
- Brystkræft37 studier
- Kræft (alle typer)33 studier
- Metastatisk cancer23 studier
- Lungecancer22 studier
- Pladecellekræft i hoved og hals22 studier
- Ægstockræft21 studier
- Colorektal kræft20 studier
- Prostatakræft20 studier
- Opioidoverdosis18 studier
- Alkoholforbrug (AUD)17 studier
- Akut myeloid leukæmi17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.